Prognia
Drug Database
🇪🇺EU · EMARefusedATC: N06D

Acrescent(memantine hydrochloride;donepezil hydrochloride)

Alzheimer Disease

Marketing Authorisation Holder: H. Lundbeck A/S

INN: memantine hydrochloride;donepezil hydrochloride

Indication

Treatment of Alzheimers disease

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Acrescent — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.